AETHLON MEDICAL, INC. Deferred Revenue
AETHLON MEDICAL, INC. (AEMD) had Deferred Revenue of $344.55 thousand as of 2022-03-31, per its 10-K filed 2022-06-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2022-06-28
- 2022-03-31: Deferred Revenue, Current $344.55K.
- 2021-03-31: Deferred Revenue, Current $114.85K.
- 2020-06-30: Deferred Revenue, Current $306.73K.
- 2020-03-31: Deferred Revenue, Current $100.00K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2022-03-31 | $344.55K 10-K · filed 2022-06-28 |
| 2021-03-31 | $114.85K 10-K · filed 2022-06-28 |
| 2020-06-30 | $306.73K 10-Q · filed 2020-08-11 |
| 2020-03-31 | $100.00K 10-K · filed 2021-06-24 |
| 2019-12-31 | $100.00K 10-Q · filed 2020-02-10 |
| 2019-09-30 | $100.00K 10-Q · filed 2019-11-01 |
| 2019-03-31 | $0.00 10-K · filed 2020-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |